Immunologic aspects of hematopoietic stem-cell transplantation

Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.

Advancements in genetic engineering·2018

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.

Bone marrow transplantation·2017

Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.

Clinical and experimental immunology·2016

Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.

Bone marrow transplantation·2016

Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

Bone marrow transplantation·2016

T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.

Bone marrow transplantation·2015

cGMP-compliant large-scale manufacturing of human-induced pluripotent stem cells: current progress and challenges.

Cytotherapy·2026

The future of clinical trials of mesenchymal stromal cells in acute graft-versus-host-disease.

Cytotherapy·2026

Human mesenchymal stromal cell extracellular vesicles maintain therapeutic miRNA cargo despite exposure to cystic fibrosis bronchoalveolar lavage fluid.

Cytotherapy·2026

Nonviral transposon‑engineered stem cells characterization: dose‑dependency between vector copy number and transgene expression.

Cytotherapy·2026

Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma.

Cytotherapy·2026

Nutritional and immunologic scoring systems to predict complications and outcomes after anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma.

Cytotherapy·2026

Association of intraoperative cell salvage combined with standard allogeneic transfusion with hematological parameters and clinical outcomes in pediatric tracheoplasty: a non-randomized cohort study.

Frontiers in pediatrics·2026

Correction: Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics.

Frontiers in surgery·2026

Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients With Posttransplant Lymphoproliferative Disorder: A Single-Center Retrospective Study.

Annals of transplantation·2026

Intercostal nerve block with liposomal bupivacaine versus no regional analgesia after uniportal thoracoscopic surgery: A randomized controlled trial.

JTCVS open·2026

Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.

Journal of psychosomatic research·2026

Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.

Frontiers in immunology·2026

Related Experiment Videos

Immunologic aspects of hematopoietic stem-cell transplantation

Related Concept Videos

Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy.

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.

Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.

Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections.

Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.

cGMP-compliant large-scale manufacturing of human-induced pluripotent stem cells: current progress and challenges.

The future of clinical trials of mesenchymal stromal cells in acute graft-versus-host-disease.

Human mesenchymal stromal cell extracellular vesicles maintain therapeutic miRNA cargo despite exposure to cystic fibrosis bronchoalveolar lavage fluid.

Nonviral transposon‑engineered stem cells characterization: dose‑dependency between vector copy number and transgene expression.

Isolation of adipose-derived mesenchymal stromal cells expressing soluble forms of GAS1 and PTEN for experimental cell therapy for glioblastoma.

Nutritional and immunologic scoring systems to predict complications and outcomes after anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma.

Association of intraoperative cell salvage combined with standard allogeneic transfusion with hematological parameters and clinical outcomes in pediatric tracheoplasty: a non-randomized cohort study.

Correction: Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics.

Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients With Posttransplant Lymphoproliferative Disorder: A Single-Center Retrospective Study.

Intercostal nerve block with liposomal bupivacaine versus no regional analgesia after uniportal thoracoscopic surgery: A randomized controlled trial.

Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.

Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.

Related Experiment Videos

Immunologic aspects of hematopoietic stem-cell transplantation

Related Concept Videos

Related Articles